ArticleCell2020
Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition.
Barzin Y Nabet et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
228 papers cite itlatest 60 shown
this paperpooled ittrialcites it